We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Allogeneic haematopoietic cell transplantation offers the chance of cure for patients with transformed follicular lymphoma.
- Authors
Heinzelmann, Frank; Bethge, Wolfgang; Beelen, Dietrich Wilhelm; Stelljes, Matthias; Dreger, Peter; Engelhard, Marianne; Finke, Jürgen; Kröger, Nikolaus; Holler, Ernst; Bornhäuser, Martin; Müller, Annerose; Haubitz, Imme; Ottinger, Hellmut
- Abstract
Purpose: In patients with follicular lymphoma, secondary transformation to aggressive lymphoma (tFL) implies a poor prognosis. In principle, allogeneic haematopoietic cell transplantation (allo-HCT) offers a chance of cure for tFL but is rarely practiced. Aim of this retrospective multicenter study was to define the actual significance of allo-HCT in treatment of tFL.Methods: The database of the German Registry for Stem Cell Transplantation (DRST) was screened for patients who underwent allo-HCT for tFL 1998-2008. Confirmation of tFL-diagnosis by local and/or pathologists of the National NHL Board was mandatory for enrolment. Gaps in reported EBMT Minimum Essential Data datasets (MED-A) were filled by local DRST data managers. Relevant HCT outcome variables were evaluated by uni- and multivariate statistical analysis.Results: Median age of enrolled 33 patients was 51 years with a post allo-HCT median follow-up of 7.1 years of surviving patients. At time of HCT 24/33 patients had chemosensitive disease. In 24/33 patients reduced intensity conditioning (RIC) was used. Estimated 1, 2, 5-year overall survival (OS) and event-free survival rates were 49/39/33, and 33/30/24%. Cumulative 100 days non-relapse mortality was 25%. Chemosensitive disease, RIC, and limited chronic GvHD were identified as independent prognostic factors for OS.Conclusions: Allo-HCT offers the chance of cure for tFL.
- Subjects
LYMPHOMA treatment; HEMATOPOIETIC stem cell transplantation; CANCER relapse; CANCER prevention; HEALTH outcome assessment
- Publication
Journal of Cancer Research & Clinical Oncology, 2018, Vol 144, Issue 6, p1173
- ISSN
0171-5216
- Publication type
Article
- DOI
10.1007/s00432-018-2633-5